Actinium Pharmaceuticals, Inc.
(NYSE Amex Equities : ATNM)

( )
ATNM After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
0.01%90.691.3%$857.92m
AMGNAmgen Inc.
0.89%188.341.2%$633.58m
GILDGilead Sciences, Inc.
1.84%67.590.9%$514.47m
BIIBBiogen Inc.
2.51%332.871.3%$435.40m
REGNRegeneron Pharmaceuticals, Inc.
2.17%423.972.6%$309.18m
ILMNIllumina, Inc.
2.51%299.823.5%$302.75m
VRTXVertex Pharmaceuticals Incorporated
1.27%188.071.9%$286.68m
ALXNAlexion Pharmaceuticals, Inc.
2.77%129.422.0%$247.61m
AAgilent Technologies, Inc.
1.64%78.281.6%$135.81m
INCYIncyte Corporation
0.88%84.152.5%$133.07m
ALNYAlnylam Pharmaceuticals, Inc
0.60%83.539.2%$82.59m
BLUEBluebird Bio, Inc.
2.04%137.0314.4%$74.39m
SGENSeattle Genetics, Inc.
4.24%71.486.6%$67.96m
NKTRNektar Therapeutics
-2.18%41.695.5%$65.74m
TECHBio-Techne Corporation
1.63%191.634.7%$48.41m

Company Profile

Actinium Pharmaceuticals, Inc. engages in the development of targeted therapies for patients with cancers lacking effective treatment options. The firm's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest in order to kill those cells. Its product pipeline includes Iomab-B, Actimab-A, and Actimab-M. The company was founded in 1993 and is headquartered in New York, NY.